Novavax-Cadila JV prepares to start flu and rabies vaccine studies in India
This article was originally published in Scrip
Executive Summary
CPL Biologics (CPLB), a joint venture between Novavax and Cadila Pharmaceuticals in India, has reported multi-pronged progress and expects to initiate clinical studies of its vaccine candidates against influenza this year and rabies in 2013.